Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06739512

Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation

Efficacy and Safety of Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation: a Multicenter Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Shanghai Chest Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of pulsed field ablation (PFA) in patients with persistent atrial fibrillation (PeAF). We will compare three distinct substrate ablation strategies: anatomical guided ablation (ANAT group), electrogram guided ablation (EGM group), and extensive electro-anatomical guided ablation (EXT group). The study seeks to identify which ablation strategy yields the highest efficacy and safety profiles to potentially guide future clinical practice in the management of PeAF.

Conditions

Interventions

TypeNameDescription
PROCEDUREExtensive Electro-Anatomical Guided AblationAblation using PFA. Combination of anatomical and electrogram-guided ablation techniques.
PROCEDUREAnatomical Guided AblationAblation using PFA. Guided by anatomical landmarks without potential mapping
PROCEDUREElectrogram Guided AblationAblation using PFA. Guided by real-time electrogram characteristics from a multi-electrode catheter.

Timeline

Start date
2024-12-25
Primary completion
2025-12-01
Completion
2026-12-01
First posted
2024-12-18
Last updated
2024-12-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06739512. Inclusion in this directory is not an endorsement.